SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2008-09-22
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of sarCNU in treating patients who have
recurrent or metastatic colorectal cancer.